Your browser doesn't support javascript.
loading
RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter.
Jo, Jae-Hyun; Park, Jong-Uk; Kim, Yeong-Mu; Ok, Seon-Mi; Kim, Dong-Kyu; Jung, Dong-Hyun; Kim, Hye-Ji; Seong, Hyun-A; Cho, Hyo Je; Nah, Jihoon; Kim, Sangjune; Fu, Haiqing; Redon, Christophe E; Aladjem, Mirit I; Jang, Sang-Min.
Afiliação
  • Jo JH; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Park JU; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Kim YM; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Ok SM; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Kim DK; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Jung DH; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Kim HJ; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Seong HA; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Cho HJ; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Nah J; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Kim S; Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, 28644, Republic of Korea.
  • Fu H; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, 20892-4255, USA.
  • Redon CE; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, 20892-4255, USA.
  • Aladjem MI; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, 20892-4255, USA.
  • Jang SM; Department of Biochemistry, Chungbuk National University, Cheongju, 28644, Republic of Korea. smjang@cbnu.ac.kr.
Cell Commun Signal ; 21(1): 219, 2023 08 23.
Article em En | MEDLINE | ID: mdl-37612584
BACKGROUND: Megakaryocytes (MKs) are platelet precursors, which arise from hematopoietic stem cells (HSCs). While MK lineage commitment and differentiation are accompanied by changes in gene expression, many factors that modulate megakaryopoiesis remain to be uncovered. Replication initiation determinant protein (RepID) which has multiple histone-code reader including bromodomain, cryptic Tudor domain and WD40 domains and Cullin 4-RING E3 ubiquitin ligase complex (CRL4) recruited to chromatin mediated by RepID have potential roles in gene expression changes via epigenetic regulations. We aimed to investigate whether RepID-CRL4 participates in transcriptional changes required for MK differentiation. METHODS: The PCR array was performed using cDNAs derived from RepID-proficient or RepID-deficient K562 erythroleukemia cell lines. Correlation between RepID and DAB2 expression was examined in the Cancer Cell Line Encyclopedia (CCLE) through the CellMinerCDB portal. The acceleration of MK differentiation in RepID-deficient K562 cells was determined by estimating cell sizes as well as counting multinucleated cells known as MK phenotypes, and by qRT-PCR analysis to validate transcripts of MK markers using phorbol 12-myristate 13-acetate (PMA)-mediated MK differentiation condition. Interaction between CRL4 and histone methylation modifying enzymes were investigated using BioGRID database, immunoprecipitation and proximity ligation assay. Alterations of expression and chromatin binding affinities of RepID, CRL4 and histone methylation modifying enzymes were investigated using subcellular fractionation followed by immunoblotting. RepID-CRL4-JARID1A-based epigenetic changes on DAB2 promoter were analyzed by chromatin-immunoprecipitation and qPCR analysis. RESULTS: RepID-deficient K562 cells highly expressing MK markers showed accelerated MKs differentiation exhibiting increases in cell size, lobulated nuclei together with reaching maximum levels of MK marker expression earlier than RepID-proficient K562 cells. Recovery of WD40 domain-containing RepID constructs in RepID-deficient background repressed DAB2 expression. CRL4A formed complex with histone H3K4 demethylase JARID1A in soluble nucleus and loaded to the DAB2 promoter in a RepID-dependent manner during proliferation condition. RepID, CRL4A, and JARID1A were dissociated from the chromatin during MK differentiation, leading to euchromatinization of the DAB2 promoter. CONCLUSION: This study uncovered a role for the RepID-CRL4A-JARID1A pathway in the regulation of gene expression for MK differentiation, which can form the basis for the new therapeutic approaches to induce platelet production. Video Abstract.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histonas / Núcleo Celular Idioma: En Revista: Cell Commun Signal Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histonas / Núcleo Celular Idioma: En Revista: Cell Commun Signal Ano de publicação: 2023 Tipo de documento: Article
...